key: cord-0759217-ym2jracl authors: Jian, Ming-Jr; Chung, Hsing-Yi; Chang, Chih-Kai; Lin, Jung-Chung; Yeh, Kuo-Ming; Chen, Chien-Wen; Lin, De-Yu; Chang, Feng-Yee; Hung, Kuo-Sheng; Perng, Cherng-Lih; Shang, Hung-Sheng title: SARS-CoV-2 Variants with T135I Nucleocapsid Mutations may Affect Antigen Test Performance date: 2021-11-07 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.11.006 sha: c40cb5068fa343c373c6748f55fcdaf083b435e7 doc_id: 759217 cord_uid: ym2jracl Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic. Additionally, several SARS-CoV-2 variants have continuously challenged diagnostic testing due to viral diversity in spike and nucleocapsid (N) protein mutations. SARS-CoV-2-variant proliferation potentially affects N protein-targeted rapid antigen testing. We performed rapid antigen and reverse transcription polymerase chain reaction (RT-PCR) tests simultaneously in patients with suspected coronavirus disease 2019 (COVID-19). To determine the N protein variations, direct whole-genome sequencing was performed, and the viral assemblies were uploaded to GISAID. We compared their genomes with those of global virus strains from GISAID. These isolates belonged to the B.1.1.7 variant, exhibiting several amino acid substitutions, including D3L, R203K, G204R, and S235F N protein mutations. We also identified the T135I mutation in one variant case in which rapid antigen and RT-PCR tests were discordantly negative and positive, respectively. Our findings suggest that the variants undetected by the PanbioTM COVID-19 rapid antigen test may be due to N-protein T135I mutations, posing a potential diagnostic risk to commercially available antigen tests. Hence, we recommend concomitant paired rapid antigen tests and molecular diagnostic methods to detect SARS-CoV-2. False-negative results could be rapidly corrected using confirmatory RT-PCR results to prevent future COVID-19 outbreaks. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), similar to other RNA viruses, continually mutates, and new variants appear and eventually become dominant. Several SARS-CoV-2 genes tend to evolve, including those encoding nucleocapsid (N) and spike (S) proteins (Dilucca et al., 2020) . By the end of December 2020, new variants had emerged and accumulated multiple mutations, termed variants of concern (VOCs), which have reportedly been associated with increased transmissibility or decreased effectiveness of available diagnostic tools (Boehm et al., 2021) . Lateral flow antigen detection diagnostics have long been deployed for various infectious diseases because of their convenience and short turnaround times (< 15 min) (Dinnes et al., 2021) . Previous studies have demonstrated the advantages and clinical performance of these rapid antigen test devices (Jungnick et al., 2021) , and their data have shown favorable performance in detecting SARS-CoV-2 VOCs using rapid antigen testing. High sensitivities have been observed in high-viral-load samples using commercial rapid antigen tests (Hayer et al., 2021) . However, N protein mutations in SARS-CoV-2 VOCs potentially lead to false-negative results with some rapid antigen tests, despite high viral load (Boehm et al., 2021) This study aimed to identify novel N protein mutation sites that affect antigen test performance. We used the Panbio TM COVID-19 antigen rapid test to screen patients with suspected COVID-19. Further, another pharyngeal specimen was used in nucleic acid amplification testing (NAAT). A total of 2496 samples were collected from patients admitted to Tri-Service General Hospital (Taipei City, Taiwan) between May and July 2021. Participants (symptomatic or non-symptomatic with a contact history with a confirmed COVID-19 case) underwent both rapid antigen testing and RT-PCR molecular assay, using paired nasopharyngeal swabs (NPSs). Both tests were performed and interpreted by on-site technicians in the same day. Two simultaneous NPSs were collected from symptomatic and asymptomatic . The first pharyngeal specimen was analyzed using the Panbio TM COVID-19 rapid antigen test (Abbott, IL, USA) as per manufacturer instructions. The second pharyngeal specimen was used in NAAT confirmation. SARS-CoV-2 infection was confirmed using RT-PCR, as previously described, with some modifications (Jian et al., 2021a) . Briefly, automated sample-to-result SARS-CoV-2 RT-PCR testing was performed using the LabTurbo AIO 48 system (LabTurbo, New Taipei City, Taiwan), with the LabTurbo AIO COVID-19 RNA testing kit for SARS-CoV-2 N1 and E genes. WGSs of the five SARS-CoV-2 strains (denoted as TSGH42-46) were performed as previously described (Jian et al., 2021b , Jian et al., 2021c . All viral assemblies were uploaded to GISAID (https://www.gisaid.org/). To investigate the amino acid variations of these five strains and identify the possible novel N protein mutations in the SARS-CoV-2 lineage, we used CoV-GLUE (http://cov-glue.cvr.gla.ac.uk) Data regarding the genome sequences of the five strains were deposited in the GISAID database, and these strains belonged to the B1.1.7 variant ( Table 1 ). The false-negative result obtained in the Panbio TM COVID-19 rapid antigen test was also verified with different lot numbers for three times, and the same result was obtained. Our analysis of the complete SARS-CoV-2 genomes of the five reported cases revealed several missense mutations. These mutations occurred in the N protein (Table 1) , including D3L, R203K, G204R, and S235F mutations in Cases 1-5. We further investigated the discordant results in Case 5 using the rapid antigen test and RT-PCR. Another novel amino acid substitution was observed in the T135I mutation in Case 5 (Figure 1 ). The Abbott Panbio™ COVID-19 Ag Rapid Test Device, which has demonstrated moderate sensitivity and specificity, was used as a screening tool (Fenollar et al., 2021) . Through WGS analysis, this study revealed a pattern of amino-acid-substitution mapping around major epitopes of the N protein. The use of other rapid antigen testing methods that detect other SARS-CoV-2-specific genes or multi-target sites as alternative method might be implemented in diagnostic laboratories. Inaccurate diagnostic test results undermine efforts at containment of the (Dinnes et al., 2021) . Because inherent lower sensitivity may be offset by combination with NAAT methods, we proposed implementing paired RT-PCR tests to counter the shortcomings of rapid antigen tests, especially their impaired ability to detect SARS-CoV-2 VOCs. Rahman et al. observed that a high-frequency co-occurring-mutation ratio (R203K and G204R) destabilized and decreased overall N protein structural flexibility (Rahman et al., 2021) . The replacement of amino acid T by I might have affect coated antibodies that recognize the SARS-CoV-2 N protein epitope. Novel SARS-CoV-2 variants: the pandemics within the pandemic Codon usage and phenotypic divergences of SARS-CoV-2 genes Emergence of N antigen SARS-CoV-2 genetic variants escaping detection of antigenic tests Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection Evaluation of the Panbio COVID-19 rapid antigen detection test device for the screening of patients with COVID-19 Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as of Novel automated sample-to-result SARS-CoV-2 laboratory-developed RT-PCR assay for high-throughput testing using LabTurbo AIO 48 system Clinical comparison of three sample-to-answer systems for detecting SARS-CoV-2 in B.1.1.7 lineage emergence Investigation of one familial cluster of COVID-19 in Taiwan: Differentiation of genetic variation among isolates and implications for epidemiological investigation and surveillance by genomic assay Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs) Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.